Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Histol Histopathol ; 28(8): 993-8, 2013 08.
Article in English | MEDLINE | ID: mdl-23371915

ABSTRACT

The progression of a tumor from benign to malign and localized to invasive and metastatic growth is the major cause of poor outcome of therapy in cancer patients. The deposition of fibrin along with other pro-coagulant molecules into the extracellular matrix obviously serves as a scaffold to support proliferation, migration and tumor cell growth as well as protection against the immune system. The use of antibodies as agents for the immunodetection of fibrin deposits in vivo has been hampered by anti-fibrin cross-reactivities with fibrinogen. For the immunohistochemical detection of fibrin we used highly specific monoclonal antibodies to a synthetic fibrinunique peptide, because the fibrin molecule shares many epitopes with fibrinogen. The monoclonal antibody was applied to adenocarcinoma of colon, mamma, pancreas, sarcoma and acute myeloic leukemia. In all tissue sections and cytospin preparations fibrin was identified in a direct apposition to the surface membranes of carcinoma and sarcoma cells, predominantly at the host-tumor interface and also in regions directly adjacent to zones of angiogenesis, whereas normal cells and tissue showed no deposits of fibrin. The findings will be supported by investigations that factors and components of the coagulation system could be detected in the tumor stroma and tumor cells. These factors are obviously produced and secreted by the malignant cells and deposited together with fibrinogen into the extracellular matrix. Our results show that basically all malignant cells examined, independently of ectodermal or mesenchymal derivation, themselves are the origin of hypercoagulability and fibrinolytic system inhibition.


Subject(s)
Antibodies, Monoclonal/chemistry , Fibrin/chemistry , Immunohistochemistry/methods , Neoplasms/metabolism , Adenocarcinoma/metabolism , Cell Line, Tumor , Cell Movement , Cell Proliferation , Disease Progression , Epitopes/chemistry , Extracellular Matrix/metabolism , Female , Fibrinogen/chemistry , Fibrinolysis , Gene Expression Regulation, Neoplastic , Humans , Immune System , Male , Neoplasm Metastasis , Peptides/chemistry
2.
Eur Arch Otorhinolaryngol ; 264(12): 1431-6, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17639446

ABSTRACT

Tumorigenesis involves energy production by aerobic glycolysis ("Warburg effect") in malignant tumors. One of the key enzymes is transketolase. Transketolase, transketolase-like-1 (TKTL1), and transketolase-like-2 are known. Antibodies against TKTL1 exist for immunohistochemical investigations. This study investigated the influence of TKTL1 on survival and metastasizing in 40 laryngeal squamous cell carcinomas (SCCs, T2-T4, 27 metastasized). Staining was assessed by an immunoreactive score (IRS) with values from 0 to 12 in primaries and their nodal metastases. The highest IRS was 8. Normal epithelium did not show an expression. Three SCCs were negative. Advanced SCCs had a higher IRS than lower stages. An IRS>4 was associated with a shorter disease specific survival, independent on the tumor stage in the multivariate analysis. Significant differences between metastasized and non-metastasized SCCs were absent, but poorly differentiated SCCs had a higher IRS in their metastases than moderate differentiated SCCs. TKTL1 overexpression is associated with a more aggressive behavior and shorter survival of laryngeal SCCs. These observations could lead to additional therapeutic options targeting a blocking of the enzyme activity.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/mortality , Laryngeal Neoplasms/metabolism , Laryngeal Neoplasms/mortality , Transketolase/metabolism , Adult , Aged , Carcinoma, Squamous Cell/secondary , Female , Follow-Up Studies , Humans , Kaplan-Meier Estimate , Laryngeal Neoplasms/pathology , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Staging , Survival Rate
3.
Cell Microbiol ; 9(2): 450-62, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16953800

ABSTRACT

Guinea pigs are highly susceptible to Legionella pneumophila infection and therefore have been the preferred animal model for studies of legionellosis. In this study guinea pig infections revealed that the Legionella virulence factor Mip (macrophage infectivity potentiator) contributes to the bacterial dissemination within the lung tissue and the spread of Legionella to the spleen. Histopathology of infected animals, binding assays with components of the extracellular matrix (ECM), bacterial transmigration experiments across an artificial lung epithelium barrier, inhibitor studies and ECM degradation assays were used to elucidate the underlying mechanism of the in vivo observation. The Mip protein, which belongs to the enzyme family of FK506-binding proteins (FKBP), was shown to bind to the ECM protein collagen (type I, II, III, IV, V, VI). Transwell assays with L. pneumophila and recombinant Escherichia coli HB101 strains revealed that Mip enables these bacteria to transmigrate across a barrier of NCI-H292 lung epithelial cells and ECM (NCI-H292/ECM barrier). Mip-specific monoclonal antibodies and the immunosuppressants rapamycin and FK506, which inhibit the peptidyl prolyl cis/trans isomerase (PPIase) activity of Mip, were able to inhibit this transmigration. By using protease inhibitors we found that the penetration of the NCI-H292/ECM barrier additionally requires a serine protease activity. Degradation assays with (35)S-labelled ECM proteins supported the finding of a concerted action of Mip and a serine protease. The described synergism between the activity of the collagen binding Mip protein and the serine protease activity represents an entirely new mechanism for bacterial penetration of the lung epithelial barrier and has implications for other prokaryotic and eukaryotic pathogens.


Subject(s)
Bacterial Proteins/metabolism , Epithelial Cells/microbiology , Extracellular Matrix/microbiology , Legionella pneumophila/physiology , Peptidylprolyl Isomerase/metabolism , Animals , Cells, Cultured , Guinea Pigs , Legionella pneumophila/genetics , Legionella pneumophila/pathogenicity , Lung/cytology , Lung/microbiology
4.
Int J Med Microbiol ; 295(3): 179-85, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16044857

ABSTRACT

In the human stomach Toll-like receptors (TLRs) expressed by the gastric epithelium interact with Helicobacter pylori and mediate production of proinflammatory cytokines and chemokines during H. pylori infection. This results in chronic active gastritis, the background from which gastric carcinoma arises via the epithelial precursor lesions, intestinal metaplasia and dysplasia. Therefore, the question is arising whether gastric carcinoma cells are also able to interact with H. pylori. In this study, TLR4, TLR5 and TLR9 expression was investigated on tumor cells of gastric carcinoma and on its precursor lesions, intestinal metaplasia and dysplasia, by immunohistochemistry. Gastric epithelium with intestinal metaplasia (n=10) and dysplasia (n=3) expressed TLR4 and TLR5. TLR4 was strongly expressed by tumor cells of 17 out of 22 and TLR5 by tumor cells of all 22 patients with gastric carcinoma. TLR9, however, was not detectable in intestinal metaplasia or dysplasia and only focally in 6 out of 22 gastric carcinomas. In contrast to H. pylori gastritis, epithelial TLR expression in intestinal metaplasia, dysplasia and gastric carcinoma was diffusely distributed without subcellular polarization as demonstrated by confocal microscopy. This is the first study describing TLR expression on tumor cells of gastric carcinoma and its precursor lesions. Expression of TLRs enables gastric carcinoma cells to interact with H. pylori. As H. pylori can induce gastric carcinoma-promoting factors, such as IL-8, via epithelial TLR expression, TLR expression by gastric carcinoma cells may have a dangerous potential.


Subject(s)
Gastric Mucosa/immunology , Helicobacter pylori/metabolism , Membrane Glycoproteins/analysis , Receptors, Cell Surface/analysis , Stomach Neoplasms/immunology , Epithelial Cells/chemistry , Epithelial Cells/immunology , Epithelial Cells/pathology , Gastric Mucosa/chemistry , Gastric Mucosa/pathology , Gastritis/immunology , Gastritis/pathology , Helicobacter Infections/immunology , Helicobacter Infections/pathology , Humans , Immunochemistry , Membrane Glycoproteins/metabolism , Metaplasia , Microscopy, Confocal , Receptors, Cell Surface/metabolism , Toll-Like Receptor 4 , Toll-Like Receptor 5 , Toll-Like Receptor 9 , Toll-Like Receptors
5.
Infect Immun ; 72(12): 6773-9, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15557597

ABSTRACT

In Helicobacter pylori gastritis, neutrophil activation and migration, which play central roles in the pathogenesis of the disease, are regulated by the neutrophil attractant chemokines interleukin 8 (IL-8) and Groalpha, whose secretion is induced by H. pylori. However, the modulation of the corresponding chemokine receptors CXCR1 and CXCR2 on human neutrophils under the influence of H. pylori has not been investigated. Incubation of neutrophils with cag(+) and cag deletion H. pylori strains resulted in a complete downregulation of the CXCR1 and the CXCR2 receptors after 0.5 h, as tested by fluorescence-activated cell sorter analysis, independent of the cag status. Downregulation of CXCR1 and CXCR2 seems to occur via receptor internalization and rapid degradation, as shown by confocal microscopy and immunoblotting. Neither the proinflammatory cytokines IL-8 and tumor necrosis factor alpha produced by the neutrophils themselves nor H. pylori lipopolysaccharide, which are the known regulators of these two chemokine receptors, was responsible for the downregulation. Reverse transcription-PCR analysis showed that CXCR1 and CXCR2 mRNAs of neutrophils were reduced at a later time than the CXCR1 and CXCR2 proteins. Moreover, cag(+) H. pylori strains induced significantly stronger downregulation of CXCR1 and CXCR2 mRNAs than the cag deletion mutant. Therefore, receptor protein and mRNA downregulation seem to be mediated by two independent mechanisms. Data obtained by immunohistochemistry suggested that downmodulation of CXCR1 and CXCR2 on neutrophils may also occur in vivo in the human stomach during H. pylori infection. Downregulation of CXCR1 and CXCR2 expression on neutrophils in H. pylori infection by H. pylori itself may represent a new mechanism of modulating neutrophil migration and activation in the gastric mucosa.


Subject(s)
Helicobacter Infections/immunology , Helicobacter pylori/pathogenicity , Neutrophils/chemistry , Receptors, Interleukin-8A/analysis , Receptors, Interleukin-8B/analysis , Down-Regulation , Humans , Interleukin-8/biosynthesis , Lipopolysaccharides/toxicity , Neutrophils/physiology , RNA, Messenger/analysis , Receptors, Interleukin-8A/genetics , Receptors, Interleukin-8A/metabolism , Receptors, Interleukin-8B/genetics , Receptors, Interleukin-8B/metabolism , Tumor Necrosis Factor-alpha/biosynthesis
6.
Mol Immunol ; 41(9): 847-54, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15261456

ABSTRACT

UNLABELLED: Histone-deacetylase (HDAC) -inhibitors enhance acetylation of core proteins and this is linked to formation of transcriptionally active chromatin in various cells. In this study, the effect of HDAC inhibitors (butyrate, trichostatin A (TSA)) on the expression of the cathelicidin LL-37 in colon, gastric and hepatocellular cells was investigated. METHODS: LL-37 expression was assessed in colon, gastric and hepatocellular cancer cells after treatment with HDAC-inhibitors. In parallel, histone H4 and HMGN2, a non-histone protein, acetylation was evaluated. In addition, the intracellular signalling pathway MEK-ERK was explored. RESULTS: In contrast to normal colon epithelial cells, gastrointestinal cancer cells lacked LL-37 expression. LL-37 was induced following treatment with HDAC-inhibitors in all investigated cell lines. This induction was time-dependent in butyrate-treated cells while TSA exerted a transient effect. Induction of LL-37 by butyrate was paralleled by acetylation of the histone H4 and the non-histone HMGN2. Again, TSA resulted in transient acetylation. Furthermore, inhibition of MEK-ERK blocked HDAC inhibitor-induced LL-37 expression in colonic and gastric cells. CONCLUSIONS: We have previously shown that butyrate induces LL-37 in colon epithelial cells. In the present study, we demonstrate that cathelicidin expression is modulated by HDAC-inhibitors in various gastrointestinal cells including gastric and hepatocellular cells. This is paralleled by changes in the acetylation of distinct core proteins suggesting a common regulatory mechanism of cathelicidin LL-37 regulation in these cells.


Subject(s)
Antimicrobial Cationic Peptides/metabolism , Gastrointestinal Tract/drug effects , Histone Deacetylase Inhibitors , Animals , Butyrates/pharmacology , Cathelicidins , Gastrointestinal Neoplasms/metabolism , Gastrointestinal Tract/metabolism , Humans , Hydroxamic Acids/pharmacology , MAP Kinase Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/metabolism , Phylogeny , Signal Transduction/physiology
7.
Scand J Infect Dis ; 36(11-12): 883-5, 2004.
Article in English | MEDLINE | ID: mdl-15764180

ABSTRACT

Mycobacterium szulgai is a ubiquitious non-tuberculous mycobacterium causing infection in immunocompetent and immunocompromized patients. Clinically mimicking pulmonary tuberculosis in most cases described, rarely other manifestations occur. Here we report the case of an AIDS patient with osteomyelitis of the hand and toe, accompanied by multiple cutaneous ulcers of the chest and forearm. The case highlights the unusual combination of osteomyelitis and skin ulcers without pulmonary infection and describes the likely cutaneous route of infection in a patient who keeps tropical fish.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Mycobacterium Infections, Nontuberculous/complications , Nontuberculous Mycobacteria/pathogenicity , Osteomyelitis/microbiology , Skin Ulcer/microbiology , Adult , Anti-Bacterial Agents/therapeutic use , Humans , Male , Mycobacterium Infections, Nontuberculous/drug therapy , Nontuberculous Mycobacteria/isolation & purification , Osteomyelitis/complications , Osteomyelitis/drug therapy , Skin Ulcer/complications , Skin Ulcer/drug therapy
8.
Virchows Arch ; 441(2): 143-7, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12189503

ABSTRACT

Mucosal IgA and IgG are involved in the immune defense against Helicobacter pylori in infected patients. In contrast to IgG, IgA is transported into the gastric lumen and is responsible for the first-line defense. Therefore antigens recognized by mucosal IgA are possible candidates for vaccination. This study compared the IgA and IgG immune response to H. pylori in the gastric mucosa and that in the serum of 21 patients with H. pylori gastritis by the immunoblotting technique. In particular, mucosal IgA immune response against the urease antigen of H. pylori was studied in detail, as vaccination with this antigen was not curative in men. The results show that mucosal IgA was not represented by serum IgA and IgG, and that the H. pylori specific mucosal IgA and IgG immune responses differ in antigen-recognition pattern. This disparity may reflect the different transport ways and functions of these two immunoglobulin isotypes. Furthermore, mucosal IgA specific for urease was found inconsistently in patients with H. pylori gastritis. As vaccination antigens should induce an appropriate mucosal IgA immune response against H. pylori, our findings may have important implications for the selection of antigens for vaccination against H. pylori.


Subject(s)
Antigens, Bacterial/analysis , Gastric Mucosa/immunology , Helicobacter Infections/immunology , Helicobacter pylori/immunology , Antibodies, Bacterial/immunology , Carcinoma/immunology , Carcinoma/pathology , Cells, Cultured , Female , Gastric Mucosa/pathology , Gastritis/immunology , Gastritis/microbiology , Gastritis/pathology , Helicobacter Infections/pathology , Helicobacter pylori/enzymology , Helicobacter pylori/isolation & purification , Humans , Immunoglobulin A/analysis , Immunoglobulin G/analysis , Lymphoma, B-Cell, Marginal Zone/immunology , Lymphoma, B-Cell, Marginal Zone/pathology , Male , Middle Aged , Stomach Neoplasms/immunology , Stomach Neoplasms/pathology , Stomach Ulcer/immunology , Urease/immunology , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...